We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1076
PG&E
PCG
$39.4B
| $4K | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
1077
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.36B
| $4K | ﹤0.01% |
250
| – | – |
2022 Q1
7 quarters
|
|
1078
E.W. Scripps
SSP
$248M
| $4K | ﹤0.01% |
523
| – | – |
2022 Q1
7 quarters
|
|
1079
DELISTED
Streamline Health Solutions
STRM
| $4K | ﹤0.01% |
667
| – | – |
2022 Q1
7 quarters
|
|
1080
State Street Corp Series G Preferred Stock
STT.PRG
$396M
| $4K | ﹤0.01% |
175
| – | – |
2022 Q1
7 quarters
|
|
1081
iShares 20+ Year Treasury Bond ETF
TLT
$47.7B
| $4K | ﹤0.01% |
45
| – | – |
2023 Q3
1 quarter
|
|
1082
United Airlines
UAL
$31B
| $4K | ﹤0.01% |
100
-500
| -83% | -$19.7K |
2022 Q4
4 quarters
|
|
1083
US Foods
USFD
$21.7B
| $4K | ﹤0.01% |
97
| – | – |
2022 Q1
7 quarters
|
|
1084
United Therapeutics
UTHR
$23.3B
| $4K | ﹤0.01% |
16
| – | – |
2022 Q1
7 quarters
|
|
1085
Vishay Precision Group
VPG
$809M
| $4K | ﹤0.01% |
+122
| New | +$3.82K |
2023 Q4
0 quarters
|
|
1086
Wabtec
WAB
$48.4B
| $4K | ﹤0.01% |
34
-184
| -84% | -$20.8K |
2022 Q1
7 quarters
|
|
|
AXA
1087
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $4K | ﹤0.01% |
129
| – | – |
2022 Q1
7 quarters
|
|
1088
BlackRock Science and Technology Trust
BST
$1.65B
| $3K | ﹤0.01% |
75
| – | – |
2022 Q1
7 quarters
|
|
1089
Coeur Mining
CDE
$15.8B
| $3K | ﹤0.01% |
1,050
| – | – |
2023 Q3
1 quarter
|
|
1090
United States Copper Index Fund
CPER
$740M
| $3K | ﹤0.01% |
120
| – | – |
2022 Q1
7 quarters
|
|
1091
Coupang
CPNG
$25.8B
| $3K | ﹤0.01% |
+157
| New | +$2.59K |
2023 Q4
0 quarters
|
|
1092
Dollar General
DG
$29.4B
| $3K | ﹤0.01% |
21
-60
| -74% | -$7.28K |
2022 Q1
7 quarters
|
|
1093
DocuSign
DOCU
$14.3B
| $3K | ﹤0.01% |
52
| – | – |
2023 Q2
2 quarters
|
|
1094
Fluor
FLR
$6.23B
| $3K | ﹤0.01% |
+80
| New | +$2.96K |
2023 Q4
0 quarters
|
|
1095
Fox Class A
FOXA
$27.5B
| $3K | ﹤0.01% |
112
| – | – |
2022 Q1
7 quarters
|
|
1096
Gaming and Leisure Properties
GLPI
$11.3B
| $3K | ﹤0.01% |
70
| – | – |
2022 Q1
7 quarters
|
|
1097
HCA Healthcare
HCA
$98.5B
| $3K | ﹤0.01% |
11
-309
| -97% | -$76.4K |
2023 Q3
1 quarter
|
|
1098
Huntington Ingalls Industries
HII
$10.6B
| $3K | ﹤0.01% |
12
| – | – |
2022 Q1
7 quarters
|
|
1099
Harley-Davidson
HOG
$2.78B
| $3K | ﹤0.01% |
80
| – | – |
2022 Q1
7 quarters
|
|
1100
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.19B
| $3K | ﹤0.01% |
85
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.